<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30186486</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">1792-0981</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>16</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Experimental and therapeutic medicine</Title>                <ISOAbbreviation>Exp Ther Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report.</ArticleTitle>            <Pagination>                <MedlinePgn>2527-2533</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2018.6507</ELocationID>            <Abstract>                <AbstractText>A newly-developed platform, integrating subtraction enrichment and immunostaining-fluorescence <i>in situ</i> hybridization (SE-iFISH), was applied to analyze the clinical significance of circulating tumor cells (CTCs) for early screening of cancer in healthy people. The present case report describes one healthy individual who accepted a CTC peripheral blood test, and 8 CTCs/7.5 ml blood were detected. However, various conventional cancer biomarkers were all negative, including cervical cytological inspection, alpha-fetoprotein, cancer antigen (CA)-125, CA19-9, carcinoembryonic antigen (CEA), CA15-3 and human papilloma virus. To explore the origin of the CTCs, whole exome sequencing was used to analyze the CTC variation spectrum. A total of 42 mutations were associated with cancer according to analysis in COSMIC (http://cancer.sanger.ac.uk/cosmic). The results revealed a high risk of tumor in the colorectum, stomach and breast (13, 12 and 6 variations matched, respectively). In this individual, an intestinal polyp was discovered and removed by colonoscopy. The intestinal polyp was identified to be a hyperplastic polyp by pathological diagnosis. No lesions were discovered in the stomach and breast. No CTCs were detected in this patient's blood at 1 and 6 months after removal of the lesions. This case indicates that CTC detection by SE-iFISH has potential in early stage cancer screening, and the mutation spectrum of CTC assists the tracking of its sources.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Su</LastName>                    <ForeName>Zijian</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgical Oncology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian 362000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhao</LastName>                    <ForeName>Jiangman</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Biotecan Medical Diagnostics Co., Ltd., Zhangjiang Center for Translational Medicine, Shanghai 200120, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ke</LastName>                    <ForeName>Shaoying</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgical Oncology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian 362000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Jian</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgical Oncology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian 362000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liu</LastName>                    <ForeName>Xiaoyu</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgical Oncology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian 362000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Yu</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Biotecan Medical Diagnostics Co., Ltd., Zhangjiang Center for Translational Medicine, Shanghai 200120, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sun</LastName>                    <ForeName>Qihong</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Biotecan Medical Diagnostics Co., Ltd., Zhangjiang Center for Translational Medicine, Shanghai 200120, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pan</LastName>                    <ForeName>Qunxiong</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgical Oncology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian 362000, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>23</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Exp Ther Med</MedlineTA>            <NlmUniqueID>101531947</NlmUniqueID>            <ISSNLinking>1792-0981</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Pathol. 2001 Mar;193(3):283-5</RefSource>                <PMID Version="1">11241405</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gastroenterology. 2015 Oct;149(5):1177-1190.e3</RefSource>                <PMID Version="1">26216840</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Biotechnol. 2014 May;32(5):479-84</RefSource>                <PMID Version="1">24752078</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Oct 31;9(10):e111597</RefSource>                <PMID Version="1">25360587</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2015 Mar 1;21(5):1098-105</RefSource>                <PMID Version="1">25524311</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2013 Sep 19;369(12):1106-14</RefSource>                <PMID Version="1">24047060</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2008 Jul 1;26(19):3213-21</RefSource>                <PMID Version="1">18591556</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2014 May 15;20(10):2553-68</RefSource>                <PMID Version="1">24831278</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Mar 28;8(13):21639-21649</RefSource>                <PMID Version="1">28423493</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2015 Mar 1;136(5):1228-33</RefSource>                <PMID Version="1">25042121</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2014 Aug 30;5(16):6594-602</RefSource>                <PMID Version="1">25026283</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2004 Aug 19;351(8):781-91</RefSource>                <PMID Version="1">15317891</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2015 Apr 20;33(12):1348-55</RefSource>                <PMID Version="1">25800753</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2012 Jan 20;148(1-2):349-61</RefSource>                <PMID Version="1">22265420</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Dis Colon Rectum. 2004 Dec;47(12):2101-4</RefSource>                <PMID Version="1">15657661</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2015 Sep 29;6(29):27049-64</RefSource>                <PMID Version="1">26267323</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Clin Pathol. 2003 Jun;119(6):778-96</RefSource>                <PMID Version="1">12817424</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Science. 2013 Mar 29;339(6127):1546-58</RefSource>                <PMID Version="1">23539594</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2014 Mar;11(3):129-44</RefSource>                <PMID Version="1">24445517</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jan 31;8(5):8801-8806</RefSource>                <PMID Version="1">28187533</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2016 Apr 12;35:66</RefSource>                <PMID Version="1">27066900</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Mar 23;10(3):e0121920</RefSource>                <PMID Version="1">25799539</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Histopathology. 2000 Oct;37(4):295-301</RefSource>                <PMID Version="1">11012735</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Pathol. 1999 Jan;52(1):5-9</RefSource>                <PMID Version="1">10343605</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">cancer screening</Keyword>            <Keyword MajorTopicYN="N">circulating tumor cell</Keyword>            <Keyword MajorTopicYN="N">intestinal polyp</Keyword>            <Keyword MajorTopicYN="N">laser capture microdissection</Keyword>            <Keyword MajorTopicYN="N">whole exome sequencing</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>27</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30186486</ArticleId>            <ArticleId IdType="doi">10.3892/etm.2018.6507</ArticleId>            <ArticleId IdType="pii">ETM-0-0-6507</ArticleId>            <ArticleId IdType="pmc">PMC6122440</ArticleId>        </ArticleIdList>        <?pmcsd?>    </PubmedData></PubmedArticle></PubmedArticleSet>